BridgeMD
New treatment option for Knee Osteoarthritis
Official title Intra-articular Corticosteroid Injection in GAE for Knee Knee Osteoarthritis
ClinicalTrials.gov ID: NCT06514716
What this study is testing
- What it's testing
- The goal of this clinical trial is to investigate the effectiveness and safety of intra-articular corticosteroid injection (IACI) in alleviating post-procedural pain and improving early outcomes in patients undergoing geniculate artery embolization (GAE) for knee osteoarthritis (OA). The main questions it aims to answer are: Does intra-articular corticosteroid injection reduce pain levels post-procedure compared to GAE alone?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Adults aged 18 years and older
- Diagnosed with knee osteoarthritis (OA) based on clinical and radiographic criteria.
- Eligible for geniculate artery embolization (GAE) as determined by the treating physician.
- Able to provide informed consent and comply with the study protocol.
You likely can't join if
- Contraindications to corticosteroid injections or geniculate artery embolization.
- Pregnant or breastfeeding women.
- Active infection or skin condition at the injection site.
- Severe cardiovascular, renal, or hepatic diseases that may affect study participation.
- Previous knee surgery within the last 6 months.
- Participation in another clinical trial within the last 30 days.
See the full eligibility criteria
- Adults aged 18 years and older
- Diagnosed with knee osteoarthritis (OA) based on clinical and radiographic criteria.
- Eligible for geniculate artery embolization (GAE) as determined by the treating physician.
- Able to provide informed consent and comply with the study protocol.
- Contraindications to corticosteroid injections or geniculate artery embolization.
- Pregnant or breastfeeding women.
- Active infection or skin condition at the injection site.
- Severe cardiovascular, renal, or hepatic diseases that may affect study participation.
- Previous knee surgery within the last 6 months.
- Participation in another clinical trial within the last 30 days.
- Inability to comply with follow-up visits or complete study assessments.
The study team makes the final eligibility decision.
Where it's taking place
- Zagazig, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Zagazig, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.